Current controversies in the management of pediatric patients with well-differentiated nonmedullary thyroid cancer: a review

W Hung, NJ Sarlis - Thyroid, 2002 - liebertpub.com
Current treatment strategies for pediatric patients with nonmedullary, well-differentiated
thyroid carcinoma (WDTC) are derived from single-institution clinical cohorts, reports of …

Imaging of the thyroid in benign and malignant disease

CM Intenzo, HQ Dam, TA Manzone, SM Kim - Seminars in nuclear …, 2012 - Elsevier
The thyroid gland was one of the first organs imaged in nuclear medicine, beginning in the
1940s. Thyroid scintigraphy is based on a specific phase or prelude to thyroid hormone …

Effect of distance between decaying 125I and DNA on Auger-electron induced double-strand break yield

P Balagurumoorthy, X Xu, K Wang… - … journal of radiation …, 2012 - Taylor & Francis
Purpose: To determine the possible effects of 125I-to-DNA distance on the magnitude and
mechanism of Auger-electron induced-double-strand break (DSB) production. Materials and …

Self-stunning in thyroid ablation: evidence from comparative studies of diagnostic 131I and 123I

TE Hilditch, MF Dempsey, AA Bolster… - European journal of …, 2002 - Springer
Twenty-six patients who had undergone recent surgery for differentiated thyroid cancer were
investigated using iodine-131 iodide (120 MBq). Uptake in the thyroid bed was measured at …

Comparison of outcomes after 123I versus 131I preablation imaging before radioiodine ablation in differentiated thyroid carcinoma

EB Silberstein - Journal of Nuclear Medicine, 2007 - Soc Nuclear Med
Detection of residual tissue after thyroidectomy for papillary or follicular thyroid carcinoma
may be performed using diagnostic imaging with either 123I or 131I. The former is often …

Iodine-123 as a diagnostic imaging agent in differentiated thyroid carcinoma: a comparison with iodine-131 post-treatment scanning and serum thyroglobulin …

M Urhan, S Dadparvar, A Mavi, M Houseni… - European journal of …, 2007 - Springer
Purpose Using 123 I for diagnostic purposes avoids the risk of stunning for subsequent
radioiodine treatment and affords an excellent image quality. In this study we assessed the …

[HTML][HTML] To treat or not to treat: the role of adjuvant radioiodine therapy in thyroid cancer patients

M Carballo, RM Quiros - Journal of oncology, 2012 - hindawi.com
Radioactive iodine (RAI) is used in treatment of patients with differentiated papillary and
follicular thyroid cancer. It is typically used after thyroidectomy, both as a means of imaging …

Controversies in the follow-up and management of well-differentiated thyroid cancer.

MD Ringel, PW Ladenson - Endocrine-Related Cancer, 2004 - erc.bioscientifica.com
Thyroid cancer is a common malignancy with an apparent increasing incidence and a wide
spectrum of clinical behavior and therapeutic responsiveness. Recent advances in …

I-123 diagnostic thyroid tumor whole-body scanning with imaging at 6, 24, and 48 hours

SK Gerard, RR Cavalieri - Clinical nuclear medicine, 2002 - journals.lww.com
Purpose The use of I-123 in lieu of I-131 for diagnostic whole-body thyroid tumor scanning
(DxRaI) in patients with differentiated thyroid cancer obviates the risk for stunning and …

Isotope imaging for metastatic thyroid cancer

BR Haugen, EC Lin - Endocrinology and Metabolism Clinics, 2001 - endo.theclinics.com
Radioiodine is uniquely concentrated in thyroid cells and many thyroid cancer cells by
uptake through the sodium-iodine symporter and organificationl trapping by thyroid …